• Analysts report that the surge in AI adoption has exposed a major bottleneck: limited access to GPU processing power
• The emerging neocloud boom aligns with BluSky AI’s mission to make advanced AI infrastructure accessible to everyone
• BluSky AI’s strategy is not just about infrastructure; it’s about accessibility and inclusion

A seismic shift is underway in the digital world as demand for “neoclouds,” specialized cloud systems optimized for today’s artificial intelligence (“AI”), accelerates at an unprecedented rate. At the center of this transformation stands BluSky AI (OTC: BSAI), which is developing scalable neocloud infrastructure designed to democratize access to AI resources for businesses, universities, and enterprises worldwide.

Analysts report that the surge in AI adoption has exposed a major bottleneck: limited access to GPU processing power (ibn.fm/drCfj). Traditional hyperscale cloud providers, such as Amazon Web Services and Microsoft Azure, are struggling to meet AI’s specialized computational demands. Enter the neocloud, which offers a more flexible, agile model that provides GPU-as-a-Service, as well as CPU and LPU services enabling users to deploy and scale AI workloads with greater efficiency and at lower cost.

Analysts projected that the global neocloud market could grow at a compound annual rate of 82% between 2021 and 2025, driven by a capacity-constrained data-center landscape and the explosion in AI demand. That projection couldn’t be more true. Neocloud operators can stand up high-density GPU infrastructure far faster than hyperscalers can build new centers, offering tailored services for machine learning, training, AI Inference and high-performance computing applications. That ability to move quickly and price competitively gives neocloud providers a powerful edge in the evolving AI economy.

While hyperscalers will continue to dominate general-purpose cloud services, experts believe that neoclouds will thrive by serving the specialized workloads that fuel AI innovation. Their smaller footprints and custom GPU provisioning make them ideal for developers, researchers and institutions that require high-speed processing without the long-term commitments or massive overhead of traditional cloud environments.

This emerging neocloud boom aligns directly with BluSky AI’s mission to make advanced AI infrastructure accessible to everyone, from startups to global enterprises. The company’s neocloud initiative introduces a modular infrastructure model that adapts to a client’s specific computational needs, allowing seamless scaling as workloads expand (ibn.fm/KaPg9). Unlike traditional data centers, which often take years to build and deploy, BSAI’s approach is nimble and decentralized. Its proprietary modular design allows for incremental expansion, faster deployment, high security, and reduced costs, all factors that make it ideal for supporting the AI-driven future outlined by analysts.

BluSky AI’s strategy is not just about infrastructure; it’s about accessibility and inclusion. The company envisions a future in which computational power is as readily available as internet bandwidth. Its neocloud platform connects clients to powerful infrastructure without the need for massive upfront investment, opening the door for smaller organizations, developers and innovators to participate in the AI revolution. BluSky AI’s future neocloud will deploy GPUs, CPUs, and LPUs, all important computing components in the full AI compute spectrum. This commitment to accessibility reflects a broader market trend toward decentralization in data processing, where agility and proximity to users increasingly determine success.

BluSky’s innovation extends beyond the corporate world through its University GPU initiative (ibn.fm/RJm4i). This program provides academic institutions with affordable access to high-performance GPU clusters, enabling students and researchers to engage with the same computational resources that power today’s most advanced AI systems. 

By lowering the barriers to entry for academic AI exploration, BSAI will not only build market share, but the company plans to help nurture the next generation of AI talent. BluSky AI’s university GPU program demonstrates how the company’s neocloud model bridges the gap between commercial, research and educational applications. As universities expand their AI and data-science programs, access to scalable GPU resources becomes vital. With a BluSky AI SkyMod placed on a college campus, this infrastructure will empower an institution to run complex models, train neural networks and engage in real-world AI experimentation without the need for costly hardware investments.

As AI adoption continues its meteoric rise, neoclouds are poised to become the backbone of the next digital era. BSAI’s innovations position the company squarely at the forefront of this transformation. With its modular SkyMod design, cost-effective infrastructure, and its commitment to democratizing AI, the company is well positioned to capitalize on one of the fastest-growing technological trends.

For more information, visit the company’s website at BluSkyAIDataCenters.com.

NOTE TO INVESTORS: The latest news and updates relating to BSAI are available in the company’s newsroom at https://ibn.fm/BSAI

• Strawberry Fields REIT, Inc., a self-administered real estate investment trust that acquires and leases properties to be used for skilled nursing and healthcare services, continues to carve out market share of the elderly care market, which is estimated to be valued at $98.19 billion by 2032, up from $49.29 billion in 2024
• This growth will be attributed to the aging baby boomer population, with every single boomer in the U.S. expected to be 65 years or older by 2030
• The company, which only holds the properties while others operate the centers, currently holds long-term leasehold interests in 142 healthcare facilities, totaling over 15,500 licensed beds

Strawberry Fields REIT (NYSE: AMERICAN: STRW), a self-administered real estate investment trust engaged in the ownership, acquisition, and leasing of skilled nursing and specific other healthcare-related properties, continues on an aggressive expansion plan as it works to carve out a decent market share of the elderly care market in the United States. Valued at $49.29 billion in 2024 and estimated to grow to $98.19 billion by 2032, representing a CAGR of 9% between 2025 and 2032, Strawberry Fields recognizes the huge untapped opportunity therein. It is positioning itself to take advantage of this impending growth (https://ibn.fm/YiCVp).

Various factors have been cited for the value uptick, with the aging baby boomer population in the country being key among them. According to the U.S. Census Bureau, in 2020, there were approximately 76.4 million baby boomers in the country. Between 2010 and 2020, the population of individuals aged 65 years and older increased by 38%, and it is estimated to grow to 80.8 million by 2040. In addition, it is projected that by 2030 every boomer will be 65 years or older, meaning that one in five Americans will be a senior citizen (https://ibn.fm/pjGAy).

With the growth in the aging population comes a steadily increasing need for elderly care. Through its ambitious expansion plan, the company is strategically positioning itself via acquisitions and leases that currently span ten states. As of September 2025, the company owns and holds long-term leasehold interests in 142 healthcare facilities, totaling over 15,500 licensed beds. In addition, its growing portfolio includes 130 skilled nursing facilities (“SNFs”), ten assisted living facilities (“ALFs”), and two long-term acute healthcare hospitals (“LTACHs”).

Its recent expansions have included nine SNFs in Missouri, totaling 686 beds for $59 million; an 80-bed SNF in Oklahoma for $4.25 million; and a 124-bed facility comprised of 108 skilled nursing beds and 16 assisted living beds near Poplar Bluff in Missouri. While appearing on The Bell2Bell Podcast, CEO Moishe Gubin pointed out that these expansions demonstrate the company’s financial discipline and consistency, noting that the company only distributes 45% to 50% of its Adjusted Funds from Operations (“AAFO”), with the remaining 50% channeled toward additional asset purchases. As a result, its value per share has grown at an annual rate of 11.1%.

For company information, visit the company’s website at www.StrawberryFieldsREIT.com.

NOTE TO INVESTORS: The latest news and updates relating to STRW are available in the company’s newsroom at https://ibn.fm/STRW

This article has been disseminated on behalf of Lahontan Gold and may include a paid advertisement.

• The broader gold market provides a powerful backdrop for Lahontan’s efforts
• CEO emphasizes Nevada as the best mining jurisdiction in the world, highlighting the advantages of Lahontan’s Santa Fe property
• Lahontan is pursuing two permits simultaneously: one for exploration and another for mining operations

Investors looking for to leverage the significant growth in the gold sector are paying close attention to Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF), a Canadian mineral exploration company advancing four high-quality gold and silver properties in Nevada’s prolific Walker Lane trend. During a recent interview at the prestigious Beaver Creek Summit with Red Cloud TV host Mark Bunting, Lahontan Gold CEO Kimberly Ann outlined the company’s progress, its flagship Santa Fe project, and the path ahead as the company works toward production.

The broader gold market provides a powerful backdrop for Lahontan’s efforts. Gold has long been regarded as a hedge against inflation, currency depreciation and global market volatility. In 2025, those qualities are in sharp focus as prices remain near historic highs. Spot gold has traded above $3,700 an ounce this year, driven by a weaker U.S. dollar, softer real interest rates and ongoing demand from both investors and central banks (ibn.fm/tef5V).

According to the World Gold Council, central banks purchased a record 1,037 tonnes of gold in 2023, marking the highest level of net purchases since records began, and demand has remained strong through 2024 and 2025 (ibn.fm/OFmth). This consistent buying underscores the role of gold as a strategic reserve asset while offering further support to prices.

One of the clearest signals of gold’s investment allure this year has been the resurgence of investment demand. In the second quarter of 2025, global gold demand grew by 3% year-over-year to 1,249 metric tons, while investment demand, including ETF inflows and OTC trades, jumped 78%. The value of that demand soared by 45% to approximately $132 billion (ibn.fm/EZVRJ).

In a Beaver Creek Summit interview, Ann emphasized Nevada as the best mining jurisdiction in the world, highlighting the advantages of Lahontan’s Santa Fe property. “It’s really an easy story to tell,” she said, noting that Santa Fe is a past producing mine with existing infrastructure, a substation and water rights, an especially critical asset in Nevada. The project also carries a long history of environmental compliance, with a perfect 35-year record tied to its closure bond. These factors, she explained, give Lahontan a head start as it advances permitting and prepares for development.

Santa Fe is central to Lahontan’s growth story. The company plans to release an updated preliminary economic assessment in early 2026, building on recent drilling campaigns and expanded metallurgical testing. Ann pointed out that the last PEA was based on $1,950 pit shells and $2,050 gold, levels that now look conservative in light of current prices. With updated data and stronger gold fundamentals, the forthcoming PEA is expected to be significantly more robust. “There’s so much opportunity here, and I feel very stoked about the fact that we had the vision during COVID . . . to focus on getting to production,” she told Red Cloud TV.

Permitting is another major focus for the company. Ann explained that Lahontan is pursuing two permits simultaneously: one for exploration and another for mining operations. The exploration plan has already been deemed complete, allowing the company to drill across the entire property without additional approvals. The mine plan of operations, meanwhile, has been designed to remain within the existing footprint, enabling a simpler environmental assessment pathway. These parallel permitting efforts keep Lahontan on track to begin construction in early 2027, depending on approvals.

Looking ahead, Ann underscored the company’s strong investor base. Lahontan trades on both the TSX Venture Exchange and the OTCQB, ensuring access to U.S. investors who already make up more than half of its shareholder base. She also highlighted the stock’s liquidity and significant retail participation. “We’ve gone up 700% since the beginning of the year, and we’re going to continue to climb. So, I feel very comfortable where we sit today,” she stated.

As Lahontan Gold continues to advance its Nevada portfolio, the combination of a world-class jurisdiction, a robust flagship project and record-high gold prices highlights the opportunities available in junior gold exploration and development.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

• Two executives with near-term gold producer LaFleur Minerals recently appeared on CEO.CA’s Inside the Boardroom podcast to discuss activity at their Swanson Gold Deposit, in the globally recognized Abitibi Gold District of Quebec
• LaFleur is exploring approximately 18,304 hectares (45,230 acres) at Swanson, with the potential of expanding its land package to follow mineral structures crossing the site
• LaFleur is distinctive in that it has drilling infrastructure on site, a tailings facility, and a 750-metric-ton-capable mill for processing ore at its nearby Beacon Gold Mill, along with positive returns from its initial diamond drilling program at Swanson
• The company recently closed a fully subscribed equity offering, and is exploring other financing structures and additional opportunities as it completes a PEA and prepares for restart of its wholly owned mill that was idled by a previous owner following the post-pandemic gold plunge, offset now by gold’s record highs

Gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is on the cusp of realizing its verticals-driven strategy for mining and processing gold ore from its Swanson Gold Deposit in the prolific Abitibi Gold District of Quebec –  Canada’s largest gold producing district.

“There are two major structures that run through Swanson that host gold and even base metals,” LaFleur CEO Paul Ténière said during a recent interview with CEO.CA’s Inside the Boardroom podcast (https://ibn.fm/LYcjm).

LaFleur Minerals has drilled 24 holes to date on the approximately 18,304-hectare (45,230-acre), district-scale Swanson site. As of the end of September, six of the holes had been assayed and showed high-grade, near-surface intercepts, according to company statements. 

In a district where several gold projects are in process, LaFleur is excited about its prospects and anticipating its potential for growth. 

“We’ve done a pretty good job of consolidating originally around the Swanson deposit and have grown it to as it is,” Ténière told Inside the Boardroom’s host. “There are other opportunities, especially to the south and southeast of Swanson. … And so, what we’re looking at doing is consolidating and adding claims from adjacent properties into (Swanson) to continue to expand. And the good news with that is that once we consolidate, we also have a rig available that we can actually start drilling on right away. And some of (the) known gold showings and base metal showings are quite exciting.”

The company’s true strength is in the vertical integration of its own fully permitted and recently refurbished gold mill, tailings facility and its advanced exploration project and gold resource as source of material, positioning it competitively in the current high gold price environment. The company expects to use the mill for processing its ore in-house, but also anticipates the potential of contracting for custom milling work with a number of other nearby gold projects in need of such milling to drive near-term revenue. 

“We do need money to restart the mill,” LaFleur Chairman Kal Malhi acknowledged alongside Ténière during the interview. “We’re talking to several opportunities, either with royalty companies or forward sales of the gold production and that will hopefully bring in some very strong gold industry partners to the deal as well.” 

LaFleur completed a non-brokered private placement equity round last month and is also finalizing flow-through financing, bringing the company closer to 80 million shares, Malhi said. 

LaFleur also expects to wrap up a comprehensive Preliminary Economic Assessment (“PEA”) for Swanson around the end of October, which is led by reputable global consulting firm Environmental Resources Management (“ERM”) and brings a highly experienced technical team to deliver a robust mining and economic study for the restart of the Beacon Gold Mill using mineralized material primarily supplied from the company’s Swanson Gold Deposit.. Gold’s record prices topping $4,000 an ounce recently, in a remarkable comeback from 2022’s $1,600 level (https://ibn.fm/yGllm), are generating enthusiasm for the market and LaFleur’s verticals-driven strategy. 

“Our mill alone is valued at $70 million, our market cap now is about $42 (million)-$43 million. Again, the totality of the deal really is I think an exciting investment opportunity,” Malhi said. 

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

This article has been disseminated on behalf of ESGold and may include a paid advertisement.

• ESGold Corp., a development stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, has inked a C$9 million binding term sheet with Ocean Partners UK Ltd.
• The facility bolsters the company’s financial position while affording it flexibility as it advances exploration on its Montauban facility
• The funds will be drawn in two tranches of C$3 million and C$6 million, respectively, both dependent on anticipated Phase 1 and Phase 2 production on the facility
• This validates the company’s strategy of advancing permitted, low-capex projects designed to generate high-margin returns while minimizing dilution

ESGold (CSE: ESAU) (OTCQB: ESAUF), an development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just inked a C$9 million binding term sheet with Ocean Partners UK Ltd. This agreement bolsters the company’s financial position, while affording it flexibility as it continues to explore and advance its Montauban Gold-Silver Project in Quebec. It is an incredible milestone that guarantees a stable, long-term sales channel for all its gold and silver dore, while further creating certainty around revenue realization and reinforcing the project’s economic foundation (https://ibn.fm/lisS4).

The Montauban project boasts a rich mining history dating back to the early 1900s. Located just 80km west of Quebec City, this facility combines immediate revenue potential for ESGold with transformational exploration upside. So far, the company has invested over C$15 million in infrastructure, including power access, roads, and a 20,000 sq. ft. processing facility, demonstrating its confidence in the facility and its economic potential.

All permits for production are in place. Construction is underway, and on track to kick off production in 2026. The Ocean Partners funding commitment aims to make this a reality, while also providing an opportunity to generate cash flow without diluting its equity.

“This agreement with Ocean Partners is an important step forward for ESGold,” noted Gordon Robb, ESGold’s CEO.

“Ocean Partners’ support ensures that debt obligations will be serviced through operating cash flow rather than equity dilution, while establishing a stable long-term sales channel for the gold and silver dore produced from Montauban,” he added (https://ibn.fm/lisS4).

The C$9 million facility will be drawn in two tranches. The first, a C$3 million tranche, will be available three months before anticipated Phase 1 production, which is expected in February 2026. The second tranche of C$6 million will be available approximately five months before Phase 2 production, which is projected for March 2027. Its repayment will be made through dore deliveries in line with structured schedules per tranche, with Ocean Partners set to purchase 100% of the gold and silver dore from Montauban tailings and crown pillar material, subject to minimum deliveries of 50,000 oz of gold and 1,000,000 oz of silver.

“The Montauban project is exactly the type of innovative opportunity in which we like to be involved,” noted Brent Omland, Ocean Partners’ CEO. “ESGold has found an economically viable path forward for precious metal production from tailings and surface rock. We are very pleased to form a long-lasting partnership with the ESGold team and are excited about the long-term potential in this area of Quebec,” he added (https://ibn.fm/lisS4).

With this agreement, ESGold is now a fully funded company with the financial strength, strategic partnerships, and operational readiness to meet its 2026 Montauban production deadline. It also positions it ahead of competitors while further validating the company’s strategy of advancing permitted, low-capex projects designed to generate high-margin returns while minimizing dilution. As such, it points to ESGold’s future success as it firmly asserts its position as a leader in its space.

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

This article has been disseminated on behalf of PowerBank and may include paid advertising.

• The company reported a 1,508% increase in revenues from its IPP segment in FY 2025.
• Total company assets rose 253% year-over-year, driven by IPP expansion and strategic project acquisitions.
• Gross margin improved to 25% from 20% in FY 2024.
• The company announced up to US$100 million in project-based financing through a mandate with CIM Group.
• PowerBank’s development pipeline now totals 1,806 (MWdc, MWh) of solar PV and battery energy storage projects.
• CEO Dr. Richard Lu highlighted a transition toward long-term recurring revenue through asset ownership and financing.

Disseminated on behalf of PowerBank Corporation

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., recently released its financial results for Fiscal Year 2025, which underscore a pivotal shift toward becoming a stable, asset-backed independent power producer (https://ibn.fm/jRa6y). The company’s strategy to retain and finance more of its energy assets appears to be taking shape, reflected in a significant increase in IPP revenue and asset growth during the fiscal year ended June 30, 2025.

While total revenues fell 29% to C$41.5 million (US$ 29.76 million), PowerBank’s IPP segment grew exponentially, posting C$9.3 million (US$ 6.67 million) compared to just C$0.6 million (US$ 0.43 million) in FY 2024, a 1,508% jump. The company’s gross margin also improved to 25% from 20%, indicating higher margins from IPP operations.

Total current assets climbed to C$41.3 million (US$ 29.61 million), up from C$17.6 million (US$ 12.62 million) a year earlier. The growth was fueled by the expansion of the IPP portfolio, new project financing agreements, and an increasingly diverse pipeline of renewable energy developments.

PowerBank ended FY 2025 with C$14.9 million (US$ 10.68 million) in cash, restricted cash, and short-term investments. The company also raised approximately US$8.5 million through a registered direct offering and could potentially secure an additional US$10.65 million if all related warrants are exercised.

PowerBank’s management has emphasized that FY 2025 was a transition year. The acquisition of Solar Flow-Through Funds Ltd. (“SFF”) early in the year, valued at up to C$45 million (US$ 32.27 million), added 29 MW of operating assets and set the foundation for sustained, recurring income streams.

“PowerBank’s strategic focus is growing its independent power producer asset base, creating long term revenues for years to come,” said Dr. Richard Lu, PowerBank’s president and CEO. “This means more projects retained and a longer cycle as PowerBank works to finance these assets to retain ownership.”

A potential catalyst for PowerBank’s growth is its announced financing with CIM Group, which provides for up to US$100 million in project-based financing. The funds, once the transaction closes, will support a portfolio of up to 97 MW of solar projects in the U.S., helping accelerate PowerBank’s goal of scaling its IPP base without diluting shareholders.

The company’s development pipeline now spans 942 MW of solar PV and 864 MWh of battery energy storage system (“BESS”) capacity, a combined 1,806 MW/MWh of potential future assets. These projects are divided into operational, under construction, advanced development, and early-stage development phases, providing a clear roadmap for future growth.

Among its deals completed during the financial year, PowerBank entered an agreement with Qcells to sell and build four ground-mounted solar projects in upstate New York totaling 25.6 MW. The combined value of the sale and EPC contracts is approximately US$49.5 million, with PowerBank expected to retain operations and maintenance contracts after completion. Two of these projects have already begun construction and two remain subject to permitting.

PowerBank continues to develop multiple BESS projects in Ontario, two of which are supported by a C$25.8 million (US$ 18.50 million) project finance facility from the Royal Bank of Canada. The SFF-06 project, featuring a 4.99 MW BESS, is already under construction and expected to begin operations by year-end and the other project (903) remains in permitting.

The company also reported delays in the permitting process for other Ontario projects (OZ-1 and 903 (noted above)), citing ongoing municipal reviews and appeals. PowerBank has filed force majeure notices to preserve its rights under existing contracts and continues to work through planning and approval challenges.

Beyond traditional solar and storage, during the fiscal year PowerBank announced its intent to enter the data center energy supply market. While still exploratory, the company said it is in discussions with potential partners and customers as it evaluates opportunities to provide power infrastructure to this rapidly expanding sector.

PowerBank is positioning itself to become a more stable, cash-generating independent power producer. Its participation in programs such as Nova Scotia’s Community Solar initiative, which recently granted three of the projects it is developing for a third party a total of C$1.74 million (US$ 1.25 million) in funding, adds another layer of regional diversification.

Dr. Lu noted that new U.S. incentives under the “One Big Beautiful Bill Act” have created an opportunity to fast-track projects qualifying for full investment tax credits. Combined with PowerBank’s activity under Canada’s IESO Long-Term RFP framework, the company appears to be laying the groundwork for sustained growth.

“The company has prioritized development pathways in key U.S. states where site control, interconnection progress, and permitting are sufficiently advanced to qualify for full ITC treatment under the new rules. In parallel, PowerBank’s diversified footprint across Canada offers resilience against U.S. policy risk. The company is currently deploying battery storage systems in Ontario under the Independent Electricity System Operator’s (‘IESO’) Long-Term RFP framework, which is designed to secure clean, dispatchable capacity through decade-long contracts,” Dr. Lu explained. “PowerBank is also a leader in Nova Scotia’s Community Solar program, where it holds significant market share and is actively expanding.”

For more information, visit the company’s website at https://PowerBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “PowerBank Announces Fiscal Year End Results” and dated October 2, 2025, for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• The closing of the public offering provides the company with critical financial flexibility as it continues to advance its pipeline of products.
• The $7.5 million raised through the public offering is particularly significant in the context of Soligenix’s ongoing clinical development programs.
• SNGX notes multiple potential value drivers over the next 18 months, including clinical milestones, regulatory interactions and data readouts across its pipeline.

Soligenix (NASDAQ: SNGX) recently announced the closing of a $7.5 million public offering, providing the company with additional capital to advance its pipeline (https://ibn.fm/tCsub). This funding extends Soligenix’s cash runway through the end of 2026, ensuring that the company has the financial resources to reach key inflection points across its portfolio, including late-stage clinical trials and regulatory milestones. The move underscores Soligenix’s commitment to advancing therapies for rare diseases where there is significant unmet medical need.

The successful closing of the public offering provides Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases, with critical financial flexibility as it continues to advance its pipeline of orphan and fast-track designated products (https://ibn.fm/3ZF0q). The company’s portfolio includes treatments for cutaneous T-cell lymphoma (HyBryte(TM) or “SGX301”), mild-to-moderate psoriasis (“SGX302”), Behçet’s disease (“SGX945”) and oral mucositis in head and neck cancer (“SGX942”), as well as several vaccines for emerging infectious diseases. According to the company, these assets represent multiple potential value drivers, with combined estimated global market potential exceeding $2 billion annually.

The $7.5 million raised through the public offering is particularly significant in the context of Soligenix’s ongoing clinical development programs. For HyBryte, the company is conducting a confirmatory phase 3 multicenter, double-blind, placebo-controlled study with approximately 80 patients diagnosed with early-stage cutaneous T-cell lymphoma (“CTCL”). The funding ensures that this pivotal study, as well as related regulatory engagements with the U.S. Food and Drug Administration (“FDA”) and European Medicines Agency (“EMA”), can continue uninterrupted through 2026. HyBryte has already demonstrated positive phase 3 results, and the confirmatory trial is a critical step toward potential commercialization and the broader availability of this first-in-class therapy for a rare patient population.

Beyond HyBryte, the funding provides Soligenix with the resources to advance its other high-potential pipeline candidates. SGX302, a therapy for mild-to-moderate psoriasis, is in phase 2a testing, and SGX945, targeting Behçet’s disease, has completed a phase 2a proof-of-concept study. Both programs represent substantial commercial opportunities in areas of unmet need, with estimated global market potential of more than $1 billion for psoriasis and more than $200 million for Behçet’s disease. By securing additional capital, Soligenix positions itself to execute these studies efficiently while maintaining strategic flexibility to pursue additional development or partnership opportunities.

The company notes multiple potential value drivers over the next 18 months, including clinical milestones, regulatory interactions and data readouts across its pipeline. These events are expected to provide a series of inflection points that could materially enhance the company’s valuation. The public offering allows Soligenix to maintain momentum across these programs, reducing the risk of delays due to funding constraints and ensuring that development timelines remain on track.

Strategically, extending the company’s cash runway through 2026 is crucial for both operational stability and investor confidence. It allows Soligenix to navigate the final stages of pivotal trials, prepare for potential product launches and continue discussions with regulatory agencies without the immediate need to secure additional capital. This financial security is particularly valuable in the rare disease space, where clinical programs can be resource-intensive and timelines for regulatory approval are tightly linked to sustained funding. For investors, this funding round reinforces Soligenix’s commitment to delivering on its growth strategy while protecting shareholder value.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

This article has been disseminated on behalf of New Pacific Metals and may include paid advertising.

• Silver prices have surged more than 60% this year, nearing the all-time high of $49.45 per ounce. 
• Gold prices have surged roughly 53% this year, reaching new all time highs of over $4,000 per ounce.
• In addition to strong investment appetite, industrial demand, particularly from solar and EV sectors, underpins silver’s long-term fundamentals.
• New Pacific’s Silver Sand and Carangas (starter pit) projects in Bolivia could yield nearly 19 million ounces of silver annually. 
• Carangas also has significant gold potential, strengthening project economics amid high prices, as gold reached record highs above $4,000.
• Bolivia’s October 19 presidential runoff may open the door for more foreign mining investment.

Silver prices climbed past $48 an ounce in early October, up well over 60% year-to-date and approaching the 1980 record of $49.45 (https://ibn.fm/vo2aL). The impressive surge is driven by both macroeconomic and structural factors: persistent inflation, growing industrial demand from renewable energy and electronics, and global uncertainty that is pushing investors into safe haven assets like precious metals (https://ibn.fm/t4d1l).

Industrial use is key to the growing demand and price surge. Silver demand in solar panels and electric vehicles has reached record levels, with projections that renewable infrastructure will consume more silver by 2050 than has been mined over the last five centuries. This dual role, as both an industrial and monetary asset, distinguishes silver from other commodities.

Against this backdrop, New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a Canadian exploration and development company, is drawing investor attention. The company has projects in Bolivia, Silver Sand and Carangas, that stand out as two of the largest undeveloped silver deposits globally. Together, they are projected to produce nearly 19 million ounces annually when developed.

Bolivia offers opportunity but comes with challenges. From Cerro Rico in Potosí, one of the richest deposits in history, to today’s underexplored highlands, the country remains mineral-rich. The country is the world’s fourth-largest silver producer, accounting for 5% of global supply in 2024. Yet more than 60% of its territory remains underexplored. Geological potential is significant, but slow permitting has deterred foreign capital.

The upcoming presidential runoff on October 19 could mark a turning point. The ruling MAS party, dominant for two decades, lost in August elections. Both remaining candidates have signaled greater openness to foreign investment. For companies like New Pacific, it could unlock the ability to move key projects forward.

If investment conditions improve following the election, New Pacific’s projects could help Bolivia reclaim its historical role as a central player in global silver supply, while offering shareholders leverage to one of the most dynamic commodities of 2025.

Silver Sand is the company’s flagship in Bolivia, with potential annual production of 12 million ounces. Carangas adds at least another 6.6 million ounces of silver a year over 16 years under its preliminary economic assessment, which focused on starter pit within a much larger resource. At $24 silver, Carangas economics are already strong, with a post-tax NPV5% of $501 million, an internal rate of return of 26%, and a 3.2-year payback period. All-in sustaining costs are projected at $7.60 per ounce. With silver prices now over $48 an ounce, the project’s leverage to rising prices is substantial, highlighting its strong economic potential.

What makes Carangas more compelling is its gold upside. Exploration indicates over 1.3 million ounces of gold potential at depth, not yet included in the PEA. With gold trading above $4,000, the addition of gold credits could substantially enhance project economics and offer a hedge if silver prices consolidate. On October 8, gold reached a new record price of $4,050 an ounce, marking a 53% increase so far this year (https://ibn.fm/l5JoT).

For more information, visit the company’s website at www.NewPacificMetals.com/welcome.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP

• Lantern’s RADR(R) AI platform is helping identify optimal indications and pathways for precision cancer therapies.
• Dr. Schalop reflects on lessons from developing ONC201, approved for H3K27M-mutant glioma, after a 16-year journey.
• Both leaders highlight the potential for AI to accelerate regulatory reviews and clinical trial design.
• The conversation underscores how AI could reduce oncology drug timelines and costs, improving patient access to new treatments, and how STAR-001, Lantern’s new CNS cancer drug, can benefit from these AI-driven insights.

In oncology, the path from molecule discovery to patient treatment often stretches over a decade and can consume hundreds of millions of dollars. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, aims to challenge that timeline. 

In a recent discussion titled “From Discovery to Clinical Trials to Patients: Key Decisions Shaping Novel CNS Oncology Medicines,” Lantern CEO Panna Sharma and new board member Dr. Lee Schalop, co-founder of Oncoceutics and a key figure behind the development of ONC201 (dordaviprone), explored how data science and machine learning could shorten the journey from lab to clinic in central nervous system (“CNS”) oncology (https://ibn.fm/vC0Ma).

Dr. Schalop, who began his career on Wall Street before earning a medical degree in his 40s, said his unique background helped him bridge science and strategy. “I realized I could probably do more by combining my business background with my new medical knowledge,” he said. That blend of experience ultimately led him to co-found Oncoceutics, where ONC201 became one of the first drugs approved for H3K27M-mutant glioma, a rare and aggressive brain cancer. Now joining Lantern’s board, Schalop brings both a cautionary and optimistic view of how the next generation of CNS drugs can be developed faster and smarter, especially through the use of artificial intelligence.

ONC201’s development began with phenotypic screening: testing compounds for general anti-cancer activity without knowing their mechanism of action. Working with the Broad Institute, Schalop’s team discovered that the molecule showed particular efficacy against brain cancer.

However, identifying the precise genetic context (the H3K27M mutation) took years of additional preclinical and clinical work. The breakthrough came during a Phase 2 trial at Harvard, when one patient’s tumor disappeared. That patient, it turned out, was the only one with the H3K27M mutation. “An AI-type program would have known about this, because it was known at this time, although just not well known,” Schalop said. “And it would have immediately put the pieces together and said, ‘Aha, this patient had it, no one else did. This is where you should devote your effort.’”

Sharma agreed that machine learning systems could have accelerated those insights. Lantern’s own platform, RADR(R) is designed to perform precisely that function. Built to analyze vast genomic and clinical datasets, RADR(R) identifies which cancer subtypes and mutations are most likely to respond to specific compounds. The platform supports Lantern’s three lead drug candidates and an antibody-drug conjugate (“ADC”) program across 12 cancer indications.

For Sharma, the promise of AI isn’t just speed, but accuracy and the ability to select the right patient populations early and design smarter trials. He cited STAR-001, a Lantern program targeting CNS cancers, as a candidate that could follow a more efficient path than traditional drug development.

The discussion also turned to the U.S. Food and Drug Administration and how regulators might use AI to shorten the pre-review phase of drug approvals. Schalop explained that it took 16 years to get ONC201 from discovery to approval. Even if the FDA can shorten its review timeline, the real opportunity is to make the 10 years before that faster, he added.

Both speakers mentioned growing interest in artificial intelligence uses within the agency, as current commissioner Marty Makary has discussed using AI to process and analyze complex scientific submissions more efficiently. Sharma added that Lantern is already deploying AI internally to summarize trial data in hours rather than weeks. “Scientific review and biomedical literature review and data review and analysis take a long time for humans to do well,” he said. “If you can get systems to do it even better and do it within minutes, as opposed to weeks or months,” that is a real game changer.

Oncoceutics’ lean approach (roughly $25 million in equity and a similar amount in grants) kept control in the founders’ hands but extended the timeline. Eventually, the company was acquired by Chimerix and later by Jazz Pharmaceuticals, which brought ONC201 to approval at a total cost of around $300-$400 million.

By contrast, AI-assisted development could lower both timelines and costs. Identifying optimal indications early reduces the number of unsuccessful trials, while predicting effective combinations may limit expensive exploratory work.

Schalop noted that AI could also make combination trials more feasible: “If you can figure out how something will probably work, as opposed to might work, it will be worth spending the time and money to try that combination.”

Both Sharma and Schalop emphasized that the ultimate goal of these technologies is to improve outcomes for patients with rare, hard-to-treat cancers. Each year, roughly 2,000 U.S. patients are diagnosed with H3K27M-mutant glioma, the same group now eligible for ONC201 treatment.

For Sharma, the message is clear: oncology’s future depends on integrating clinical experience with data science. “I think it’s a great time to be in medicine. There’s just so much data and people are publishing so much. It’s an exciting time. And hopefully it translates more and more into better patient outcomes,” he concluded.

For more information, visit the company’s website at www.LanternPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to LTRN are available in the company’s newsroom at https://ibn.fm/LTRN

• Red Cat Holdings is partnering with Safe Pro Group Inc. (NASDAQ: SPAI) to outfit drones with AI threat detection technology.
• This technology, called Safe Pro Object Threat Detection (“SPOTD”), helps drones identify and locate various kinds of dangerous explosive hazards in real time.
• The technology has already performed ample real-world analysis, with more than 2 million images processed and over 36,000 landmine and unexploded ordnance (“UXO”) detected.

Safe Pro Group (NASDAQ: SPAI), a mission-driven technology company that delivers AI-powered security solutions, recently collaborated with Red Cat Holdings to embed AI threat detection into Red Cat’s Black Widow(TM) drones (https://ibn.fm/NXv7N).

The move has generated market attention for Red Cat, as SPAI’s technology enables the drones to identify and find explosive threats in real-time. The Black Widow(TM) will also integrate with Safe Pro’s new SPOTD Navigation, Observation and Detection Engine (“NODE”), a powerful, edge-based solution designed to process, map and share mission critical information collected by drones. This appeals to both military and security clients, and lets teams on the ground navigate dangerous terrain and environments in a safer way.

The AI threat detection capabilities of the drones are powered by Safe Pro Object Threat Detection (“SPOTD”), a technology that was developed for the modern battlefield, where personnel on the ground are exposed to various small and difficult-to-see threats.

This patented drone-based imagery analysis platform is able to see and identify more than 150 threats such as landmines, UXO, and cluster munitions. The technology is battle-tested, and has nearly three years of real-world usage in Ukraine. 

Throughout this time, it has processed over two million images, analyzed more than 28 TB of data, detected more than 36,000 landmines and UXO, and has surveyed over 9166 hectares (more than 22,600 acres) of land.

In addition to this large dataset of landmines and UXO, SPOTD features AI algorithms that are trained to recognize threats. It accurately labels and tags landmines and UXO that can then display the results on high-resolution maps to give teams a birds-eye view of their surroundings to improve safety and situational awareness.

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group (NASDAQ: SPAI) is a technology company that’s delivering advanced and cutting-edge AI-powered defense and security solutions. The company’s AI image technology enables real-time detection of various threats, is already operating at scale, and has more than two years of real-world usage so far.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI